Yi Hu

7PUBLICATIONS
1CO-AUTHORS
Cancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 31, 2023
Deciphering pathogenic cellular module at single-cell resolution in checkpoint inhibitor-related pneumonitis.

Pengfei Cui, Jinfeng Li, Haitao Tao

|Mar 19, 2021
The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors.

Zhaozhen Wu, Pengfei Cui, Haitao Tao

|Sep 10, 2020
Anti-PD-1/L1 plus anti-angiogenesis therapy as second-line or later treatment in advanced lung adenocarcinoma.

Di Huang, Pengfei Cui, Ziwei Huang

|May 20, 2020
Association of immune-related pneumonitis with the efficacy of PD-1/PD-L1 inhibitors in non-small cell lung cancer.

Pengfei Cui, Di Huang, Zhaozhen Wu

|Feb 14, 2020
Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer.

Di Huang, Fan Zhang, Haitao Tao

|Jan 04, 2020
Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients.

Junxun Ma, Danyang Sun, Jinliang Wang

Pageof 2

Frequent Collaborators

2 joint publications

Zhaozhen Wu